These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 25647455)

  • 1. Perioperative trajectory of patient reported symptoms: a pilot study in gynecologic oncology patients.
    Meyer LA; Nick AM; Shi Q; Wang XS; Williams L; Brock T; Iniesta MD; Rangel K; Lu KH; Ramirez PT
    Gynecol Oncol; 2015 Mar; 136(3):440-5. PubMed ID: 25647455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Symptom recovery after thoracic surgery: Measuring patient-reported outcomes with the MD Anderson Symptom Inventory.
    Fagundes CP; Shi Q; Vaporciyan AA; Rice DC; Popat KU; Cleeland CS; Wang XS
    J Thorac Cardiovasc Surg; 2015 Sep; 150(3):613-9.e2. PubMed ID: 26088408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of patient reported symptom burden on an enhanced recovery after surgery (ERAS) care pathway in patients with ovarian cancer undergoing primary vs. interval tumor reductive surgery.
    Meyer LA; Shi Q; Lasala J; Iniesta MD; Lin HK; Nick AM; Williams L; Sun C; Wang XS; Lu KH; Ramirez PT
    Gynecol Oncol; 2019 Mar; 152(3):501-508. PubMed ID: 30876495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of surgical complications on health-related quality of life in women undergoing gynecologic and gynecologic oncology procedures: a prospective longitudinal cohort study.
    Doll KM; Barber EL; Bensen JT; Revilla MC; Snavely AC; Bennett AV; Reeve BB; Gehrig PA
    Am J Obstet Gynecol; 2016 Oct; 215(4):457.e1-457.e13. PubMed ID: 27131589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Symptom burden of cancer patients: validation of the German M. D. Anderson Symptom Inventory: a cross-sectional multicenter study.
    Schmidt H; Cleeland CS; Bauer A; Landenberger M; Jahn P
    J Pain Symptom Manage; 2015 Jan; 49(1):117-25. PubMed ID: 24858739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Translation and validation of the Chinese version of the MD Anderson symptom inventory for measuring perioperative symptom burden in patients with gynecologic cancer.
    Zhang T; Zheng YY; Yang ZR; Shi Q; Wang XS; Zhao J; Yang M; Wu CL; Wang GR
    BMC Womens Health; 2021 Jul; 21(1):276. PubMed ID: 34325677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Capturing the patient's experience: using qualitative methods to develop a measure of patient-reported symptom burden: an example from ovarian cancer.
    Williams LA; Agarwal S; Bodurka DC; Saleeba AK; Sun CC; Cleeland CS
    J Pain Symptom Manage; 2013 Dec; 46(6):837-45. PubMed ID: 23615044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal perioperative patient-reported outcomes in open compared with minimally invasive hysterectomy.
    Huepenbecker SP; Iniesta MD; Wang XS; Cain KE; Zorrilla-Vaca A; Shen SE; Basabe MS; Suki T; Garcia Lopez JE; Mena GE; Lasala JD; Williams LA; Ramirez PT; Meyer LA
    Am J Obstet Gynecol; 2024 Feb; 230(2):241.e1-241.e18. PubMed ID: 37827271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of symptom burden on work-related abilities in patients with locally recurrent or metastatic breast cancer: Results from a substudy of the VIRGO observational cohort study.
    Cleeland CS; Mayer M; Dreyer NA; Yim YM; Yu E; Su Z; Mun Y; Sloan JA; Kaufman PA
    Breast; 2014 Dec; 23(6):763-9. PubMed ID: 25193423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measuring what matters MOST: validation of the Measure of Ovarian Symptoms and Treatment, a patient-reported outcome measure of symptom burden and impact of chemotherapy in recurrent ovarian cancer.
    King MT; Stockler MR; O'Connell RL; Buizen L; Joly F; Lanceley A; Hilpert F; Okamoto A; Aotani E; Bryce J; Donnellan P; Oza A; Avall-Lundqvist E; Berek JS; Sehouli J; Feeney A; Berton-Rigaud D; Costa DSJ; Friedlander ML;
    Qual Life Res; 2018 Jan; 27(1):59-74. PubMed ID: 29248998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wireless Monitoring Program of Patient-Centered Outcomes and Recovery Before and After Major Abdominal Cancer Surgery.
    Sun V; Dumitra S; Ruel N; Lee B; Melstrom L; Melstrom K; Woo Y; Sentovich S; Singh G; Fong Y
    JAMA Surg; 2017 Sep; 152(9):852-859. PubMed ID: 28593266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sleep quality and its association with fatigue, symptom burden, and mood in patients with advanced cancer in a clinic for early-phase oncology clinical trials.
    George GC; Iwuanyanwu EC; Anderson KO; Yusuf A; Zinner RG; Piha-Paul SA; Tsimberidou AM; Naing A; Fu S; Janku F; Subbiah V; Cleeland CS; Mendoza TR; Hong DS
    Cancer; 2016 Nov; 122(21):3401-3409. PubMed ID: 27412379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electronic patient-reported symptom monitoring in patients recovering from ambulatory minimally invasive gynecologic surgery: A prospective pilot study.
    Zivanovic O; Chen LY; Vickers A; Straubhar A; Baser R; Veith M; Aiken N; Carter J; Curran K; Simon B; Mueller J; Jewell E; Chi DS; Sonoda Y; Abu-Rustum NR; Leitao MM
    Gynecol Oncol; 2020 Oct; 159(1):187-194. PubMed ID: 32718730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer-related symptom assessment in France: validation of the French M. D. Anderson Symptom Inventory.
    Guirimand F; Buyck JF; Lauwers-Allot E; Revnik J; Kerguen T; Aegerter P; Brasseur L; Cleeland CS
    J Pain Symptom Manage; 2010 Apr; 39(4):721-33. PubMed ID: 20413059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of the measure of ovarian symptoms and treatment concerns: aiming for optimal measurement of patient-reported symptom benefit with chemotherapy for symptomatic ovarian cancer.
    King MT; Stockler MR; Butow P; O'Connell R; Voysey M; Oza AM; Gillies K; Donovan HS; Mercieca-Bebber R; Martyn J; Sjoquist K; Friedlander ML
    Int J Gynecol Cancer; 2014 Jun; 24(5):865-73. PubMed ID: 24844220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient-reported outcomes after oncologic hepatic resection predict the risk of delayed readiness to return to intended oncologic therapy (RIOT).
    Wang XS; Shi Q; Shen SE; Letona E; Kamal M; Cleeland CS; Aloia T; Gottumukkala V
    Eur J Surg Oncol; 2024 Jul; 50(7):108396. PubMed ID: 38754314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient-Reported Outcomes After Extensive (Ultraradical) Surgery for Ovarian Cancer: Results From a Prospective Longitudinal Feasibility Study.
    Soo Hoo S; Marriott N; Houlton A; Nevin J; Balega J; Singh K; Yap J; Sethuram R; Elattar A; Luesley D; Kehoe S; Sundar S
    Int J Gynecol Cancer; 2015 Nov; 25(9):1599-607. PubMed ID: 26397157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing symptom burden using the M. D. Anderson symptom inventory in patients with chemotherapy-induced anemia: results of a multicenter, open-label study (SURPASS) of patients treated with darbepoetin-alpha at a dose of 200 microg every 2 weeks.
    Gabrilove JL; Perez EA; Tomita DK; Rossi G; Cleeland CS
    Cancer; 2007 Oct; 110(7):1629-40. PubMed ID: 17694552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation and application of a module of the MD Anderson Symptom Inventory for measuring perioperative symptom burden in patients with gynecologic cancer (the MDASI-PeriOp-GYN).
    Wang XS; Shi Q; Williams LA; Cleeland CS; Garcia-Gonzalez A; Chen TY; Shahid DR; Ramirez PT; Iniesta MD; Siverand AM; Meyer LA
    Gynecol Oncol; 2019 Mar; 152(3):492-500. PubMed ID: 30876494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reliability and validity of the M. D. Anderson Symptom Inventory-Spine Tumor Module.
    Armstrong TS; Gning I; Mendoza TR; Vera-Bolanos E; Gilbert MR; Rhines LD; Weinberg JS; Sanchez-Williams G; Levin V; Burton AW; Cleeland C
    J Neurosurg Spine; 2010 Apr; 12(4):421-30. PubMed ID: 20367379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.